EUVIMEDEUVIMED entdecken
Leserbrief

Placebo-Arm Cirrhosis Incidence in Fibrotic MASH: A Trial-Based Benchmark

Matheus Souza iD

Digestive Diseases and Sciences · 21.08.2026

DOI: 10.1007/s10620-026-10189-0 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Digestive Diseases and Sciences, online erschienen am 21.08.2026. Verfasst von Matheus Souza. Beteiligte Einrichtung: Department of Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. matheushenrique.gs@hotmail.com. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. matheushenrique.gs@hotmail.com.

ORCID-Profile: Matheus Souza

Zitieren

APA

Souza, M. (2026). Placebo-Arm Cirrhosis Incidence in Fibrotic MASH: A Trial-Based Benchmark. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-026-10189-0

Vancouver

Souza M. Placebo-Arm Cirrhosis Incidence in Fibrotic MASH: A Trial-Based Benchmark. Digestive Diseases and Sciences. 2026. doi:10.1007/s10620-026-10189-0

BibTeX
@article{Souza2026,
  author = {Souza, Matheus},
  title = {Placebo-Arm Cirrhosis Incidence in Fibrotic MASH: A Trial-Based Benchmark},
  journal = {Digestive Diseases and Sciences},
  year = {2026},
  doi = {10.1007/s10620-026-10189-0}
}
Kostenlos starten →